Trial Profile
An observational trial to evaluate the influence of CYP3A4*1G allele on the pharmacokinetics and pharmacodynamics of clopidogrel
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Coronary disorders
- Focus Pharmacodynamics; Pharmacokinetics
- 27 Feb 2016 New trial record
- 18 Feb 2016 Results published in the European Journal of Drug Metabolism and Pharmacokinetics